events
We are thrilled to announce that ArtiQ has been acquired by Clario, a leading healthcare research and technology company renowned for its groundbreaking contributions to clinical evidence generation.
We are happy to announce our partnership with AstraZeneca, reflecting our shared dedication to advancing research on respiratory conditions and enhancing the quality of life for individuals with lung diseases.
AstraZeneca, a global pharmaceutical leader, has embarked on a transformative journey in clinical trials by integrating digital health solutions.
ArtiQ and AstraZeneca Belgium hosted Smart Spirometry webinar which explored the crucial role of spirometry in primary care, the impact of AI on workflow, and the potential for more accurate COPD diagnosis in high-risk patients.
Clario integrates AI into clinical trial data collection for spirometry with new partnership with ArtiQ
ArtiQ ranked in the CB Insights’ 2022 ‘Digital Health 150’ List
ArtiQ presented at the International Respiratory Summit at the EXPO 2020.
Watch the presentation below to get an overview of the latest applications of AI in respiratory medicine and to learn how doctors and AI can work together as a complimentary team.